![]()
|
|
||||||||
J. Biol. Chem., Vol. 277, Issue 28, 25722-25727, July 12, 2002
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
§ and
§¶
From the Rad9, Rad1, and Hus1 are members of the
Rad family of checkpoint proteins that are required for both DNA
replication and DNA damage checkpoints and are thought to function as
sensors in the DNA integrity checkpoint control. These proteins can
interact with each other and form a stable proliferating cell nuclear
antigen-related Rad9·Rad1·Hus1 heterotrimeric complex that
might encircle DNA at or near the damaged sites. In this study, we
demonstrate that the human Rad9 (hRad9) protein contains a predicted
nuclear localization sequence (NLS) near its C terminus, which plays an
essential role in the hRad9-mediated G2 checkpoint.
Deletion experiments indicate that the NLS-containing region of hRad9
is critical for the nuclear transport of not only hRad9 but also human
Rad1 (hRad1) and human Hus1 (hHus1), although this region is not
required for hRad9·hRad1·hHus1 complex formation. In
support of the role that hRad9 NLS plays in the nuclear targeting of
the hRad9·hRad1·hHus1 complex, overexpression of a deletion
mutant of hRad9 lacking the NLS-containing C-terminal region can bypass
the G2 checkpoint and result in cell death after ionizing
radiation or hydroxyurea treatment. Moreover, knockdown of hRad9
expression by small interfering RNA (siRNA) results in hRad1
accumulation in the cytoplasm and significantly abrogates the
G2 checkpoint in the presence of damaged DNA or incomplete DNA replication. Thus, the C-terminal region of human Rad9
protein is important for G2 checkpoint control by operating
the transport of the hRad9·hRad1·hHus1 checkpoint complex into the nucleus.
Drug Discovery Program, H. Lee Moffitt
Cancer Center and Research Institute and Departments of
§ Interdisciplinary Oncology and ¶ Pharmacology and
Therapeutics, University of South Florida College of Medicine,
Tampa, Florida 33612
To whom correspondence should be addressed: Drug Discovery
Program, H. Lee Moffitt Cancer Center and Research Institute, 12902 Magnolia Dr., Tampa, FL 33612. Tel.: 813-979-6764; Fax: 813-979-6748; E-mail: wanghg@moffitt.usf.edu.
This article has been cited by other articles:
![]() |
H. Yamaguchi and H.-G. Wang Tissue Transglutaminase Serves as an Inhibitor of Apoptosis by Cross-Linking Caspase 3 in Thapsigargin-Treated Cells Mol. Cell. Biol., January 15, 2006; 26(2): 569 - 579. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Takahashi, M. Karbowski, H. Yamaguchi, A. Kazi, J. Wu, S. M. Sebti, R. J. Youle, and H.-G. Wang Loss of Bif-1 Suppresses Bax/Bak Conformational Change and Mitochondrial Apoptosis Mol. Cell. Biol., November 1, 2005; 25(21): 9369 - 9382. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Dang, S. Bao, and X.-F. Wang Human Rad9 is required for the activation of S-phase checkpoint and the maintenance of chromosomal stability Genes Cells, April 1, 2005; 10(4): 287 - 295. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. M. Yiu, P. W. H. Wong, T.W. Lam, Y.C. Mui, H. F. Kung, M. Lin, and Y. T. Cheung Filtering of Ineffective siRNAs and Improved siRNA Design Tool Bioinformatics, January 15, 2005; 21(2): 144 - 151. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Jurvansuu, K. Raj, A. Stasiak, and P. Beard Viral Transport of DNA Damage That Mimics a Stalled Replication Fork J. Virol., January 1, 2005; 79(1): 569 - 580. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Llado, F. Tebar, M. Calvo, J. Moreto, A. Sorkin, and C. Enrich Protein KinaseC{delta}-Calmodulin Crosstalk Regulates Epidermal Growth Factor Receptor Exit from Early Endosomes Mol. Biol. Cell, November 1, 2004; 15(11): 4877 - 4891. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. M. Hopkins, W. Auerbach, X. Y. Wang, M. P. Hande, H. Hang, D. J. Wolgemuth, A. L. Joyner, and H. B. Lieberman Deletion of Mouse Rad9 Causes Abnormal Cellular Responses to DNA Damage, Genomic Instability, and Embryonic Lethality Mol. Cell. Biol., August 15, 2004; 24(16): 7235 - 7248. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Yin, A. Zhu, Y. J. Jin, Y.-X. Liu, X. Zhang, K. M. Hopkins, and H. B. Lieberman Human RAD9 checkpoint control/proapoptotic protein can activate transcription of p21 PNAS, June 15, 2004; 101(24): 8864 - 8869. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Iwabu, K. Smith, F. D. Allen, D. A. Lauffenburger, and A. Wells Epidermal Growth Factor Induces Fibroblast Contractility and Motility via a Protein Kinase C {delta}-dependent Pathway J. Biol. Chem., April 9, 2004; 279(15): 14551 - 14560. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Kobayashi, A. Hirano, T. Kumano, S.-L. Xiang, K. Mihara, Y. Haseda, O. Matsui, H. Shimizu, and K.-i. Yamamoto Critical role for chicken Rad17 and Rad9 in the cellular response to DNA damage and stalled DNA replication Genes Cells, April 1, 2004; 9(4): 291 - 303. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Wang, C.-L. Hsu, J. Ni, P.-H. Wang, S. Yeh, P. Keng, and C. Chang Human Checkpoint Protein hRad9 Functions as a Negative Coregulator To Repress Androgen Receptor Transactivation in Prostate Cancer Cells Mol. Cell. Biol., March 1, 2004; 24(5): 2202 - 2213. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. M. Hopkins, X. Wang, A. Berlin, H. Hang, H. M. Thaker, and H. B. Lieberman Expression of Mammalian Paralogues of HRAD9 and Mrad9 Checkpoint Control Genes in Normal and Cancerous Testicular Tissue Cancer Res., September 1, 2003; 63(17): 5291 - 5298. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. A. Greer, B. D. A. Besley, K. B. Kennedy, and S. Davey hRad9 Rapidly Binds DNA Containing Double-Strand Breaks and Is Required for Damage-dependent Topoisomerase II{beta} Binding Protein 1 Focus Formation Cancer Res., August 15, 2003; 63(16): 4829 - 4835. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Roos-Mattjus, K. M. Hopkins, A. J. Oestreich, B. T. Vroman, K. L. Johnson, S. Naylor, H. B. Lieberman, and L. M. Karnitz Phosphorylation of Human Rad9 Is Required for Genotoxin-activated Checkpoint Signaling J. Biol. Chem., June 27, 2003; 278(27): 24428 - 24437. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Yoshida, Y. Miki, and D. Kufe Activation of SAPK/JNK Signaling by Protein Kinase Cdelta in Response to DNA Damage J. Biol. Chem., December 6, 2002; 277(50): 48372 - 48378. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |